UPLC-DAD-MS Based Quality Control and Discrimination Analysis of Different Aerial Parts of Crataegus rhipidophylla Gand. Found in Indian Western Himalaya

References

• Lambert, J., Srivastava, J., Vietmeyer, N. (1997). Medicinal Plants: Rescuing a Global Heritage. The World Bank, Washington, DC.
   Google Scholar
• Blumenthal, M. (1998). The complete German commission E monographs: therapeutic guide to herbal medicines. American Botanical Council, Austin, TX,
   Google Scholar
• Rates, S.M.K. (2001). Plants as source of drugs. Toxicon. 39: 603–613.
   PubMed Web of Science ®Google Scholar
• Dubey, N.K., Kumar, R., Tripathi, P. (2004). Global promotion of herbal medicine: India’s opportunity. Current Science. 86: 37–41.
   Web of Science ®Google Scholar
• Basu, S.K., Thomas, J.E., Acharya, S.N. (2007). Prospects for growth in global nutraceutical and functional food markets: a Canadian perspective. Aust. J. Basic Appl. Sci. 1: 637–649.
   Google Scholar
• The Wealth of India. (2004). Crataegus oxyacantha: First supplement series. NISCAIR, CSIR, New Delhi, p. 2.
   Google Scholar
• Amy, B., Deanna, M., Christy, W. (2006). Hawthorn. URL: http//www.geocities.com/chadrx/hawth.html.
   Google Scholar
• Verma, S.K., Jain, V., Verma, D., Khamesra, R. (2000). Crataegus oxyacantha-A cardioprotective herb. Journal of Herbal Medicine and Toxicology. 1: 65–71.
   Google Scholar
• WHO. (2003). Monographs on medicinal plants newly independent states. 91–93.
   Google Scholar
• Huang, Y., Chen, Z.Y., Ho, W.K.K. (2004). Herbal and Traditional Medicine, Biomolecular and Clinical Aspects. China: p. 2.
   Google Scholar
• Kashyap, C.P., Arya, V., Thakur, N. (2012). Ethnomedicinal and phytopharmacological potential of Crataegus oxyacantha Linn.-A review. Asian Pacific Journal of Tropical Biomedicine. S1194–S1199.
   Google Scholar
• Kumar, D., Arya, V., Bhat, Z.A., Khan, N.A., Prasad, D.N. (2012). The genus Crataegus: chemical and pharmacological perspectives. Revista Brasileira de Farmacognosia. 22: 1187–1200.
   Google Scholar
• Miller, L.G. (1998). Botanical influences on cardiovascular disease. Alternative Medicine Review. 3: 422–431.
   PubMedGoogle Scholar
• Miller, L.G. (1998). Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Archives of Internal Medicine. 158: 2200–2211.
   PubMed Web of Science ®Google Scholar
• Krzeminski, T., Chatterjee, S.S. (1993). Ischemia and early reperfusion induced arrhythmias: beneficial effects of an extract of Crataegus oxyacantha L. Pharmaceutical and Pharmacological letters. 3: 45–48.
   Google Scholar
• Peschel, W., Bohr, C., Plescher, A. (2008). Variability of total flavonoids in Crataegus-factor evaluation for the monitored production of industrial starting material. Fitoterapia. 79: 6–20.
   PubMed Web of Science ®Google Scholar
• Chen, J.D., Wu, Y.Z., Tao, Z.L., Chen, Z.M., Liu, X.P. (1995). Hawthorn (shan zha) drink and its lowering effect on blood lipid levels in humans and rats. World Review of Nutrition and Dietetics. 77: 147–154.
   PubMedGoogle Scholar
• Ju, L.Y. (2005). Crataegus oxyacantha (aubepine) in the use as herb medicine in France. Zhongguo Zhong Yao Za Zhi. 30: 634–640.
   Google Scholar
• Hawthorne Berry info and Products (2006). http://www.bodybuilding.com/store/haw.html
   Google Scholar
• Moerman, D.E. (1998). Native American Ethnobotany. Timber Press, Portland, OR.
   Google Scholar
• Moerman, D.E. (2009). Native American Medicinal Plants. Timber Press, Portland, OR.
   Google Scholar
• Turner, N.J., Thompson, L.C., Thompson, M.T., York, A.Z. (1990). Thompson ethnobotany: knowledge and usage of plants by the Thompson Indians of British Columbia. Royal British Columbia Museum.
   Google Scholar
• Chang, Q., Zuo, Z., Harrison, F., Chow, M.S. (2002). Hawthorn. The Journal of Clinical Pharmacology. 42: 605–612.
   PubMed Web of Science ®Google Scholar
• Sticher, O., Meier, B.H. (1998). Biological activity and new strategies for quality control. Phytmedicines of Europe. Chemistry and Biological Activity. 241–262.
   Google Scholar
• Jurikova, T., Sochor, J., Rop, O., Mlcek, J., Balla, S., Szekeres, L., Adam, V., Kizek, R. (2012). Polyphenolic profile and biological activity of Chinese hawthorn (Crataegus pinnatifida BUNGE) fruits. Molecules. 17: 14490–14509.
   PubMed Web of Science ®Google Scholar
• Badalica-Petrescu, M., Dragan, S., Ranga, F., Fetea, F., Socaciu, C. (2014). Comparative HPLC-DAD-ESI (+) MS fingerprint and quantification of phenolic and flavonoid composition of aqueous leaf extracts of Cornus mas and Crataegus monogyna in relation to their cardiotonic potential. Notulae Botanicae Horti Agrobotanici Cluj-Napoca. 42: 9.
   Web of Science ®Google Scholar
• Wang, C.H., Wang, Y.X., Liu, H.J. (2011). Validation and application by HPLC for simultaneous determination of vitexin-2 3 -O-glucoside, vitexin-2 3 -O-rhamnoside, rutin, vitexin, and hyperoside. Journal of Pharmaceutical Analysis. 1: 291–296.
   PubMedGoogle Scholar
• Ficarra, P., Ficarra, R., De Pasquale, A., Monforte, M.T., Calabro, M.L. (1990). High-performance liquid chromatography of flavonoids in Crataegus oxyacantha L. IV. Reversed-phase high-pressure liquid chromatography in flower, leaf and bud extractives of Crataegus oxyacantha L. Farmaco (Societa chimica italiana: 1989). 45: 247–255.
   PubMedGoogle Scholar
• Birkler, R.I., Stottrup, N.B., Hermannson, S., Nielsen, T.T., Gregersen, N., Botke, R. H.E., Andreasen, M.F., Johannsen, M. (2010). A UPLC-MS/MS application for profiling of intermediary energy metabolites in microdialysis samples-A method for high-throughput. Journal of Pharmaceutical and Biomedical Analysis. 5: 983–990.
   Google Scholar